Nishan Sengupta, PhD

Dr Sengupta is Compound Market Access Leader–Xarelto (Rivaroxaban) Worldwide Market Access, Johnson & Johnson, Raritan, NJ

Last modified: August 18, 2011
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME